New York City HHC Former Employee Inappropriately Accesses PHI | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

New York City HHC Former Employee Inappropriately Accesses PHI

May 22, 2015
by Rajiv Leventhal
| Reprints
The New York City Health and Hospitals Corporation (HHC) has notified approximately 90,000 patients that one of the medical organization's former employees inappropriately accessed their protected health information (PHI). 
 
The former employee worked at Jacobi Medical Center (JMC), which is operated by HHC. The incident in question, which occurred on February 19, 2015, was discovered on February 27, 2015 when, in the course of HHC’s monitoring of outgoing emails, the organization identified a number of emails containing files of PHI that were accessed by a former Jacobi employee after her employment ended earlier in the month. 
 
The former employee sent these files to her personal email account. She also sent these files to the email account of her new employer, which is a New York City agency that works closely with HHC, the organization said in a statement on its website. According to the former employee, she accessed and sent the subject files to these email accounts in the event that in the future she had to respond to questions about her past work at JMC.   
 
While there is no indication that the former employer improperly used the information in these files, or that her new employer, an agency of the City of New York, has accessed, viewed or used these files, JMC says it has taken a number of steps in response. First, the organization interviewed the former employee, who said that the information she accessed was not further disseminated and was subsequently deleted from her personal computer and personal e-mail account. 
 
A later forensic review of her personal computer and confirmed that the information was in fact deleted and had not been forwarded further from that computer. Additionally, the City agency, where the former employee now works, has advised JMC that they examined their information and email systems, as well as the computer they assigned to the former JMC employee, and they advised HHC that, after a diligent search, the subject files were not present on their systems or computer devices.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Study: Use of EHRs Does Not Reduce Administrative Costs

A recent study by Duke University and Harvard Business School researchers found that costs for processing a single bill ranged from $20 for a primary care visit to $215 for an inpatient surgical procedure, or up to 25 percent of revenue.

Kibbe to Step Down as CEO of DirectTrust

David Kibbe, M.D., M.B.A., announced he would step down as president and CEO of DirectTrust at the end of the year.

Sequoia Project Exec Appointed to HITAC’s Interoperability Task Force

The Sequoia Project’s CIO/CTO, Eric Heflin, has been appointed to the Health Information Technology Advisory Committee’s (HITAC) U.S. Core Data for Interoperability Task Force (USCDI).

Healthcare Orgs Report Improvements in Quality, Cost Using Data and Analytics

In 2017, nearly three dozen organizations ranging in size from small community hospitals to some of the nation’s largest integrated delivery systems documented 125 improvements in quality, cost and efficiency using technology and improvement processes.

Consortium to Promote Implementation of a FHIR Genomics Platform

At this week’s HL7 Genomics Conference in Washington, D.C., a new group was introduced to promote implementation of a FHIR Genomics platform.

Cedars-Sinai Collaborates on Organs-on-Chip Precision Medicine Project

Scientists at Los Angeles-based Cedars-Sinai, in partnership with biotechnology startup Emulate, are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.